Mesoblast (MESO) Interest & Investment Income (2015 - 2023)
Mesoblast recorded quarterly Interest & Investment Income of $214000.0 in Q1 2023, up 38.96% quarter-over-quarter from $154000.0 in Q4 2022, and up 10800.0% year-over-year from N/an in Q1 2022.
Mesoblast's Interest & Investment Income history runs 9 years deep, the most recent figure standing at $214000.0 for Q1 2023.
- In Q1 2023, Interest & Investment Income rose 10800.0% year-over-year to $214000.0; the TTM figure through Mar 2023 stood at $430000.0 (up 2488.89% YoY), while the FY2022 annual figure was $3000.0, down 86.36% from the prior year.
- Interest & Investment Income came in at $214000.0 for Q1 2023 at Mesoblast, up from $154000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $237000.0 in Q4 2019 to a low of -$16000.0 in Q3 2021.
- A 5-year average of $83058.8 and a median of $16000.0 in 2020 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 200.0% in 2021 and soared 15300.0% in 2022, its largest moves.
- Mesoblast's Interest & Investment Income stood at $237000.0 in 2019, then plunged by 97.89% to $5000.0 in 2020, then slumped by 80.0% to $1000.0 in 2021, then jumped by 15300.0% to $154000.0 in 2022, then surged by 38.96% to $214000.0 in 2023.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $214000.0, $154000.0, and $60000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 214,000.00 |
| Dec 31, 2022 | 154,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | -2,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | -16,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 16,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Mar 31, 2020 | 120,000.00 |
| Dec 31, 2019 | 237,000.00 |
| Sep 30, 2019 | 176,000.00 |
| Jun 30, 2019 | 228,000.00 |
| Mar 31, 2019 | 207,000.00 |
| Dec 31, 2018 | 153,000.00 |
| Sep 30, 2018 | 131,000.00 |
| Jun 30, 2018 | 105,000.00 |
| Mar 31, 2018 | 79,000.00 |
| Dec 31, 2017 | 114,000.00 |
| Sep 30, 2017 | 68,000.00 |
| Jun 30, 2017 | 93,000.00 |
| Mar 31, 2017 | 81,000.00 |
| Dec 31, 2016 | 117,000.00 |
| Sep 30, 2016 | 177,000.00 |
| Jun 30, 2016 | 262,000.00 |
| Mar 31, 2016 | 292,000.00 |
| Dec 31, 2015 | 263,000.00 |